Richard Innenberg, CFA
Chief Financial Officer
Professional Overview
Richard Innenberg is an accomplished financial executive with extensive experience in the healthcare and medical device industries. As the Chief Financial Officer at Sagis Dx, he oversees all financial operations, capital planning, and strategic decision-making. Additionally, he holds several concurrent leadership roles, including serving as the President of RIM Advisors LLC, the Chief Financial Officer of BioGX, the Managing Director of Medical Device Advisory Services at New Century Capital Partners, and as a Venture Partner at Orbimed Advisors.
Experience Summary
Current Role
As the Chief Financial Officer at Sagis Dx, Richard is responsible for directing the company's financial strategy, reporting, and compliance. He works closely with the executive team to drive operational efficiency, implement robust financial controls, and support the organization's growth initiatives. Under his leadership, Sagis Dx has achieved significant milestones in product development, market expansion, and revenue growth.
Career Progression
Prior to his current roles, Richard held various senior finance and advisory positions within the healthcare and medical device sectors. He has a proven track record of successfully guiding organizations through periods of rapid change and transformation, leveraging his deep industry expertise and strategic financial acumen to drive value creation.
Academic Background
Richard holds a Bachelor of Science in Finance from the University of California, Berkeley, and is a Chartered Financial Analyst (CFA) charterholder. His academic achievements and professional certifications demonstrate his commitment to excellence and continuous learning.
Areas of Expertise
- Financial strategy and planning
- Capital raising and allocation
- Mergers, acquisitions, and integration
- Financial reporting and compliance
- Performance optimization and cost management
- Venture capital and private equity advisory
Professional Impact
Throughout his career, Richard has been instrumental in shaping the financial and operational success of several leading healthcare and medical device companies. His strategic guidance, financial expertise, and industry insights have contributed to the growth and profitability of the organizations he has served.
Conclusion
With his extensive financial leadership experience, industry knowledge, and proven track record of driving organizational transformation, Richard Innenberg is a valuable asset to the healthcare and medical device industries. He is well-positioned to continue contributing to the success of Sagis Dx and his other professional endeavors, leveraging his comprehensive skillset to create long-term value for his clients and stakeholders.